Latest filing published 23 Oct 2013 for Adma Biologics, INC., €1.9M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Burrill Capital Fund IV, L.P.: trading record in brief
Burrill Capital Fund IV, L.P. appears in our data through filings on Adma Biologics, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 13 February 2012 to 22 October 2013.
Purchases make up the whole of the open-market record (1 purchase, €1.9M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. So far in 2013, the count stands at 1 purchase and no sales.
On 23 October 2013 came the latest disclosure, an open-market purchase for €1.9M in Adma Biologics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Burrill Capital Fund IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 308,824 shares@ US$8.50Common Stock, par value $0.0001 per shareSEC:0001209191-13-048990:0Canonical exit: 20 Jan 2014 (T+90)
- 885,417 sharesCommon Stock, par value $0.0001 per shareSEC:0001193805-12-000279:0
2 of 2 declarations
